Canopy Growth Corporation Reports 13% Revenue Increase to $81.2 Million in Q1 Fiscal 2027

Canopy Growth Corporation reported its financial results for the first quarter of fiscal 2027, ending June 30, 2026, revealing a net revenue of $81.2 million, a 13% increase from $72.1 million in the same period last year. The growth was driven by a rise in both adult-use and medical cannabis sales, which contributed $29.7 million and $25.8 million, respectively. The company also noted a significant improvement in its gross margin, which rose to 27% from 25% year-over-year, reflecting effective cost management despite an increase in the cost of goods sold, which totaled $58.9 million.

The company’s net loss for the quarter was $14.6 million, a substantial reduction from a loss of $44.9 million in the prior year, marking a 68% improvement. This positive shift was attributed to a significant turnaround in other income, which moved from a loss of $21.9 million to a gain of $7.4 million, primarily due to favorable fair value changes in Canopy USA-related assets. The basic and diluted loss per share improved to $0.03 from $0.24 in the previous year.

In terms of operational developments, Canopy Growth has been focusing on strategic acquisitions and product expansions. The company completed the acquisition of MTL Cannabis Corp. in March 2026, which is expected to enhance its cultivation capabilities and product offerings. Additionally, the company continues to expand its international presence, particularly in Europe, where it has seen growth in medical cannabis sales, notably in Poland. The company’s total assets as of June 30, 2026, were reported at $1.1 billion, with cash and cash equivalents amounting to $336.6 million.

Canopy Growth's workforce has also seen changes, with a focus on optimizing operations and reducing costs. The company reported a slight increase in employee headcount, reflecting its ongoing efforts to integrate MTL and streamline operations. The company’s strategic direction includes leveraging its asset-right model to enhance profitability and expand its market share in both the Canadian and international cannabis markets.

Looking ahead, Canopy Growth remains optimistic about its growth trajectory, particularly in the U.S. cannabis market through its investment in Canopy USA. The company is actively pursuing opportunities to capitalize on the expanding market, although it acknowledges the regulatory uncertainties that may impact its operations. The management has indicated that it will continue to focus on enhancing operational efficiencies and expanding its product portfolio to meet consumer demand.